NAD+ 1000mg – Premium Bulk Nicotinamide Adenine Dinucleotide for Laboratory Research
The NAD+ 1000mg NAD+ 1000mg Peptides bulk pack delivers high-purity nicotinamide adenine dinucleotide in a sterile lyophilized form, designed exclusively for advanced scientific and laboratory research. Ideal for in vitro studies, biochemical assays, and analytical investigations, this bulk format ensures researchers have a reliable supply for ongoing experiments without interruptions.
NAD+ (Nicotinamide Adenine Dinucleotide) is a vital coenzyme present in all living cells, playing a central role in redox reactions, energy metabolism, and cellular repair pathways. This compound is a key focus in research exploring mitochondrial health, aging processes, neuroprotection, and metabolic regulation. With its importance in energy transfer, NAD+ is a cornerstone in studies aiming to better understand cellular function and longevity.
Manufactured in GMP-compliant facilities, each vial of NAD+ undergoes stringent RP-HPLC testing to achieve a purity level of ≥99%. This ensures precise, reproducible results in sensitive assays. Every pack includes a Certificate of Analysis (COA) for complete transparency on purity, identity, and composition.
Key Benefits of the NAD+ 1000mg peptides
- Bulk 1000mg supply for extended research projects
- High-purity NAD+ supports accurate experimental outcomes
- Suitable for metabolic, aging, and mitochondrial studies
- Reliable long-term storage stability
- Global temperature-controlled shipping
Specifications
- Compound: NAD+ (Nicotinamide Adenine Dinucleotide)
- Form: Lyophilized powder
- Strength: 1000mg total
- Purity: ≥99% RP-HPLC tested
- Use: For laboratory research only – not for human consumption
Whether your lab is studying cellular energy metabolism, age-related decline, or neuroprotective pathways, the NAD+ 1000mg bulk pack ensures consistent quality and availability.
Order your NAD+ 1000mg bulk supply today and keep your research moving forward without supply delays.




Reviews
There are no reviews yet.